Innate Pharma SA Class A (EURONEXT:IPH) - Share price - Overview

Stock Report

Innate Pharma SA IPH

Last Price
11.21

Day Change
0.17|1.54%

As of 28/03/2017
17:35:00 CEST | EUR
Minimum 15 Minutes Delay.

Last Close11.04
Day Range11.08 - 11.27
Mkt Cap604.00Mil
52-Wk Range8.26 - 15.83
Yield %-
ISINFR0010331421
Volume145,635
P/E-280.25
P/S18.46
P/CF-27.72

Share Price

Financials
201320142015
More ...
Income Statement
Revenue16.650.9117.91
Operating Income-2.79-19.97-10.77
Net Income-2.89-19.65-6.71
Basic EPS-0.07-0.39-0.13
Avg. Diluted Shares Outstanding395053
Balance Sheet
Current Assets49.3579.31252.13
Non Current Assets6.5311.3853.83
Total Assets55.8890.69305.96
Current Liabilities9.2810.7860.16
Total Liabilities15.6016.06233.89
Total Equity40.2974.6372.07
Cash Flow
Operating Cash Flow-10.97-18.13207.91
Capital Expenditure-0.43-2.34-7.40
Free Cash Flow-11.40-20.48200.52

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Innate Pharma SA is a biopharmaceutical company. The Company is engaged in developing immunotherapy drugs for cancer and inflammatory diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

127
Key Stats
More ...
Price/Earning TTM-276.00
Price/Book8.59
Price/Sales TTM18.66
Rev Growth (3 year avg)7.83
EPS Growth (3 year avg)-
Operating Margin % TTM-60.16
Net Margin % TTM-37.45
ROE TTM-9.14
Debt/Equity0.04
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.